title: Effects of perioperative synbiotic treatment on infectious complications, intestinal integrity, and fecal flora and organic acids in hepatic surgery with or without cirrhosis.
abstract: BACKGROUND
  The aim of this study was to assess the effect of preoperative and postoperative synbiotic treatment in hepatectomy patients with or without liver cirrhosis.
  
  
  METHODS
  Sixty-one patients with hepatic cancer were assigned randomly to receive either oral synbiotics that consisted of Bifidobacterium, Lactobacillus, and galactooligosaccharides or no synbiotics (control) preoperatively for 14 days and postoperatively for 11 days. Infectious complications, intestinal mucosal integrity as measured by serum diamine oxidase (DAO) activity, and fecal flora and organic acid concentrations were compared between synbiotic treatment (n = 32) and control (n = 29) groups.
  
  
  RESULTS
  Fecal flora culture and organic acid concentrations were changed after hepatectomy in both groups. The postsurgery decrease in DAO activity was less profound in the synbiotic-treated group (P < .01) and was correlated negatively with serum interleukin 6 and C-reactive protein concentrations (P < .001). Infectious complications occurred in 5 (17.2%) patients in the control group and no patients in the synbiotic-treated group (P < .05).
  
  
  CONCLUSIONS
  Perioperative synbiotic treatment attenuated the decrease in intestinal integrity and reduced the rate of infectious complications in patients with or without liver cirrhosis who underwent hepatic surgery.
authors.affiliation: Division of Nutrition and Metabolism, Kobe University Graduate School of Health Sciences, Kobe, Japan. musa@kobe-u.ac.jp
authors.forename: Makoto
authors.initials: M
authors.lastname: Usami
authors.forename: Makoto
authors.initials: M
authors.lastname: Miyoshi
authors.forename: Yoshihiro
authors.initials: Y
authors.lastname: Kanbara
authors.forename: Michiko
authors.initials: M
authors.lastname: Aoyama
authors.forename: Hiroe
authors.initials: H
authors.lastname: Sakaki
authors.forename: Katsuhito
authors.initials: K
authors.lastname: Shuno
authors.forename: Kenrou
authors.initials: K
authors.lastname: Hirata
authors.forename: Masanori
authors.initials: M
authors.lastname: Takahashi
authors.forename: Kimihiko
authors.initials: K
authors.lastname: Ueno
authors.forename: Shouzou
authors.initials: S
authors.lastname: Tabata
authors.forename: Takashi
authors.initials: T
authors.lastname: Asahara
authors.forename: Koji
authors.initials: K
authors.lastname: Nomoto
mesh_terms: D000143:Acids / Q000032:analysis; D000368:Aged; D006631:Amine Oxidase (Copper-Containing) / Q000097:blood; D001644:Bifidobacterium; D002097:C-Reactive Protein / Q000378:metabolism; D005243:Feces / Q000737:chemistry / Q000382:microbiology*; D005260:Female; D006801:Humans; D015994:Incidence; D007239:Infections / Q000453:epidemiology* / Q000378:metabolism; D015850:Interleukin-6 / Q000097:blood; D007413:Intestinal Mucosa / Q000378:metabolism / Q000382:microbiology; D007778:Lactobacillus; D008099:Liver / Q000601:surgery*; D008103:Liver Cirrhosis / Q000601:surgery; D008113:Liver Neoplasms / Q000601:surgery; D008297:Male; D008875:Middle Aged; D009844:Oligosaccharides / Q000494:pharmacology / Q000627:therapeutic use; D019990:Perioperative Care / Q000379:methods; D011183:Postoperative Complications / Q000453:epidemiology / Q000378:metabolism / Q000628:therapy*; D058616:Synbiotics
chemical_list: D000143:Acids; D015850:Interleukin-6; D009844:Oligosaccharides; D002097:C-Reactive Protein; D006631:Amine Oxidase (Copper-Containing)